Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat for Joint Damage in Early Gout
NCT01078389Phase 2Completed
- Sponsor
- Takeda
- Start
- Mar 2010
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in gout, hyperuricemia, sponsored by Takeda. Started Mar 2010; status: completed.
02
Drugs
febuxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT01078389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078389.